Amplitude Healthcare Acquisition Corporation (AMHCU)

Etorro trading 970x250

About Amplitude Healthcare Acquisition Corporation

Amplitude Healthcare Acquisition Corporation does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare related industries. The company was founded in 2019 and is based in New York, New York. Address: 1177 Avenue of the Americas, New York, NY, United States, 10036

Amplitude Healthcare Acquisition Corporation News and around…

Latest news about Amplitude Healthcare Acquisition Corporation (AMHCU) common stock and company :

Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.
22 Sep, 2021 FinancialContent
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members
20 Sep, 2021 FinancialContent

Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced that Lawrence Klein, Ph.D., and Chris Nolet will be appointed to Jasper Therapeutics’ board of directors, effective upon closing of the pending merger between the parties. Mr. Nolet will assume the role of Audit Committee Chair.

Jasper Therapeutics To List On NASDAQ Via SPAC Reverse Merger
06 May, 2021 FinancialContent

Biotech firm,Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal withAmplitude Healthcare ...

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
06 May, 2021 FinancialContent

Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, anticipated to occur in the third quarter 2021, the combined company will be renamed Jasper Therapeutics, Inc., and its common stock is expected to be listed on Nasdaq under the ticker symbol “JSPR.”

Amplitude Healthcare Acquisition Corporation (AMHCU) is a NASDAQ Common Stock listed in , ,

970x250